Semi-Annual Statement Of Income And Retained Earnings

COSMOS Pharmaceutical Corporation - Filing #7310433

Concept	2023-06-01 to 2024-05-31	2023-06-01 to 2024-05-31	2023-06-01 to 2024-05-31	2023-06-01 to 2024-05-31	2023-06-01 to 2024-05-31	2022-06-01 to 2023-05-31	2022-06-01 to 2023-05-31	2022-06-01 to 2023-05-31	2022-06-01 to 2023-05-31	2022-06-01 to 2023-05-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)	—	—	—	31,501,000,000 JPY	31,481,000,000 JPY	30,128,000,000 JPY	—	30,104,000,000 JPY	—	—
Non-operating income
Non-operating income	—	—	—	3,637,000,000 JPY	3,643,000,000 JPY	3,677,000,000 JPY	—	3,684,000,000 JPY	—	—
Non-operating expenses
Non-operating expenses	—	—	—	839,000,000 JPY	839,000,000 JPY	719,000,000 JPY	—	719,000,000 JPY	—	—
Ordinary profit (loss)	—	—	—	34,299,000,000 JPY	34,286,000,000 JPY	33,086,000,000 JPY	—	33,070,000,000 JPY	—	—
Extraordinary income
Extraordinary income	—	—	—	628,000,000 JPY	628,000,000 JPY	46,000,000 JPY	—	46,000,000 JPY	—	—
Extraordinary losses
Extraordinary losses	—	—	—	1,208,000,000 JPY	1,208,000,000 JPY	359,000,000 JPY	—	359,000,000 JPY	—	—
Profit (loss) before income taxes	—	—	—	33,719,000,000 JPY	33,706,000,000 JPY	32,773,000,000 JPY	—	32,757,000,000 JPY	—	—
Income taxes - current	—	—	—	9,484,000,000 JPY	9,479,000,000 JPY	9,294,000,000 JPY	—	9,288,000,000 JPY	—	—
Income taxes - deferred	—	—	—	-219,000,000 JPY	-219,000,000 JPY	-318,000,000 JPY	—	-318,000,000 JPY	—	—
Profit (loss)	24,446,000,000 JPY	24,446,000,000 JPY	24,446,000,000 JPY	24,454,000,000 JPY	24,446,000,000 JPY	23,797,000,000 JPY	23,787,000,000 JPY	23,787,000,000 JPY	23,787,000,000 JPY	23,787,000,000 JPY